Modular Medical, Inc.

Modular Medical, Inc. is a U.S.-based pre-revenue medical device company developing insulin pump systems for people with diabetes. Its core effort is to commercialize a low-cost, easier-to-use patch pump platform, starting with MODD1 and then a next-generation tubeless version called Pivot.

4.03

— Modular Medical, Inc.
%
Insulin pump devices0% Wearable insulin delivery devices designed for people requiring multiple daily insulin doses.
Next-generation patch pump platform0% Tubeless and simplified pump designs intended to improve usability and manufacturability.
Regulatory and commercialization activities0% FDA clearance, manufacturing transfer, and launch preparation needed to bring products to market.

The company targets insulin-dependent diabetes patients, especially people with type 1 diabetes and a growing type 2...

  • Type 1 diabetes patientsprimary

    Buy or are prescribed insulin pumps for continuous, wearable insulin delivery and better daily management.

  • Type 2 diabetes patients on multiple daily injectionsprimary

    Targeted as a larger, underpenetrated group that may adopt pumps if the device is simpler and lower cost.

  • Diabetes educator practicessecondary

    Prescribe and train patients on pump use, making them a key channel for adoption and support.

  • Primary care physicians and distributorssecondary

    Help reach daily insulin users who are not managed by specialist pump centers.

Modular Medical is headquartered and operates in San Diego, California, and all employees are located in the United...

  • •Headquartered in San Diego, California
  • •All employees are located in the United States
  • •Initial commercialization focus is the U.S. market
  • •FDA clearance obtained for U.S. marketing of MODD1
  • •Foreign jurisdiction approvals are a future expansion goal

The company’s strategy is to win adoption by simplifying insulin pump use, lowering training burden, and reducing cost...

01
Commercialize MODD1 and launch initial shipmentsshort-term

The company needs first product revenue and real-world adoption to validate the platform and channel strategy.

02
Obtain FDA clearance for Pivotmedium-term

Pivot is intended to replace MODD1 with a more usable and manufacturable product.

03
Build a scalable commercialization modelmedium-term

The company is trying to expand beyond specialist pump users into a broader diabetes market.

The company is pre-revenue and depends on external financing, so execution risk and dilution risk are central...

critical

Going concern and financing dependence

The company states substantial doubt about its ability to continue without additional capital.

Scope
Equity and debt financing needs to fund R&D and commercialization
Materiality
high
high

Regulatory approval and FDA compliance

Commercial launch depends on 510(k) clearance and ongoing quality-system compliance.

Scope
Product launch timing, market access, and manufacturing continuity
Materiality
high
high

Manufacturing and supply chain execution

The company must transfer production and maintain compliant contract manufacturing.

Scope
Product availability, recalls, and launch delays
Materiality
high
high

Competitive pressure from established pump makers

Medtronic, Tandem Diabetes Care, and Insulet have larger resources and installed bases.

Scope
Pricing, adoption, and physician preference
Materiality
high
medium

Reimbursement and adoption friction

Insurance coverage and training economics affect whether clinicians prescribe and support the device.

Scope
Commercial uptake and channel efficiency
Materiality
medium
Research and development expense
High and rising R&D can obscure underlying commercialization progress
Stock-based compensation
Affects operating expense and shareholder dilution
Use of estimates and accruals
Can move quarterly results materially
Going-concern assessment
Important for liquidity analysis and balance-sheet interpretation

TANDEM DIABETES CARE INC

TNDM · Surgical & Medical Instruments & Apparatus

Glucotrack, Inc.

GCTK · Surgical & Medical Instruments & Apparatus

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

INSULET CORP

PODD · Surgical & Medical Instruments & Apparatus

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

ICU MEDICAL INC/DE

ICUI · Surgical & Medical Instruments & Apparatus

: 28/04/2026